MoonLake Immunotherapeutics clinical trials we track

Check company identity source

Phase 3 7 trials

Phase 2 2 trials

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters

· 3 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Completion date type changed

Before: Estimated. After: Actual.

Recruitment status changed

Before: Active not recruiting. After: Completed.

Check registry source

· 1 field changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Response Rate of participants achieving at least a 50% improvement in the American College of Rheumatology criteria (ACR50). After: Measure: Percentage of Participants Achieving an American College of Rheumatology 50% (ACR50) Response at Week 12.

Check registry source

· 1 field changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Hidradenitis Suppurativa Clinical Response 75. After: Measure: Percentage of Participants Achieving Hidradenitis Suppurativa Clinical Response (HiSCR) 75 at Week 12.

Check registry source

· 3 fields changed

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: 17 Jun 2025. After: 2 Sep 2025.

Recruitment status changed

Before: Active not recruiting. After: Completed.

Check registry source

· 3 fields changed

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: 17 Jun 2025. After: 14 Aug 2025.

Recruitment status changed

Before: Active not recruiting. After: Completed.

Check registry source